Helius Total Assets from 2010 to 2024

HSDT Stock

USD 0.49 0.03 6.52%

Helius Medical Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2014-03-31

Previous Quarter

8.8 M

Current Value

5.6 M

Quarterly Volatility

5.9 M

Yuan Drop

Covid

Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.

Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Total Assets Growth Pattern

Below is the plot of the Total Assets of Helius Medical Technologies over the last few years. Total assets refers to the total amount of Helius Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Helius Medical Techn books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Helius Medical's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 7.69 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Helius Total Assets Regression Statistics

	Arithmetic Mean	7,283,328
	Geometric Mean	197,236
	Coefficient Of Variation	107.62
	Mean Deviation	5,798,246
	Median	6,547,000
	Standard Deviation	7,838,317
	Sample Variance	61.4T
	Range	27.8M
	R-Value	0.63
	Mean Square Error	39.5T
	R-Squared	0.40
	Significance	0.01
	Slope	1,112,496
	Total Sum of Squares	860.1T

Helius Total Assets History

	2024	9.9 M
	2023	7.7 M
	2022	17.3 M
	2021	14.1 M
	2020	6.5 M
	2019	10.3 M
	2018	27.8 M

Other Fundumenentals of Helius Medical Techn

Intangibles To Total Assets

Helius Medical Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Net Receivables	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Property Plant Equipment	Capital Stock	Good Will	Intangible Assets
Total Assets		0.74	0.7	-0.98	-0.68	0.35	0.77	0.71	0.99	0.53	-0.18	0.45	0.42	-0.09	0.69	0.45	0.11	0.86	0.84	0.51	-0.14	-0.34	-0.33
Total Stockholder Equity	0.74		0.89	-0.69	-0.62	-0.23	0.14	0.45	0.71	0.17	-0.7	0.24	0.03	-0.04	0.74	0.24	0.02	0.91	0.86	0.56	-0.3	-0.39	-0.37
Net Tangible Assets	0.7	0.89		-0.62	-0.79	-0.32	0.19	0.6	0.68	0.09	-0.7	0.55	0.2	-0.47	0.89	0.55	-0.28	0.87	0.9	0.56	-0.57	-0.69	-0.7
Net Debt	-0.98	-0.69	-0.62		0.55	-0.36	-0.79	-0.59	-0.99	-0.62	0.14	-0.35	-0.31	-0.01	-0.56	-0.35	-0.13	-0.77	-0.76	-0.35	0.04	0.25	0.24
Retained Earnings	-0.68	-0.62	-0.79	0.55		-0.01	-0.41	-0.92	-0.64	0.13	0.27	-0.81	-0.64	0.52	-0.96	-0.81	0.4	-0.85	-0.9	-0.63	0.66	0.83	0.8
Accounts Payable	0.35	-0.23	-0.32	-0.36	-0.01		0.73	0.36	0.35	0.52	0.8	0.2	0.57	0.25	-0.13	0.2	0.41	0.01	-0.08	0.05	0.29	0.35	0.33
Total Liab	0.77	0.14	0.19	-0.79	-0.41	0.73		0.63	0.8	0.62	0.39	0.43	0.58	-0.09	0.31	0.43	0.14	0.4	0.42	0.22	0.08	-0.14	-0.14
Short Long Term Debt	0.71	0.45	0.6	-0.59	-0.92	0.36	0.63		0.68	0.07	0.04	0.8	0.78	-0.44	0.85	0.8	-0.19	0.76	0.77	0.63	-0.54	-0.63	-0.61
Total Current Assets	0.99	0.71	0.68	-0.99	-0.64	0.35	0.8	0.68		0.57	-0.15	0.44	0.39	-0.1	0.64	0.44	0.07	0.81	0.81	0.42	-0.11	-0.34	-0.34
Short Term Debt	0.53	0.17	0.09	-0.62	0.13	0.52	0.62	0.07	0.57		0.15	-0.01	-0.05	0.2	-0.07	-0.01	0.51	0.14	0.06	-0.04	0.3	0.34	0.32
Common Stock	-0.18	-0.7	-0.7	0.14	0.27	0.8	0.39	0.04	-0.15	0.15		0.03	0.37	0.2	-0.48	0.03	0.07	-0.48	-0.47	-0.38	0.29	0.34	0.32
Long Term Debt	0.45	0.24	0.55	-0.35	-0.81	0.2	0.43	0.8	0.44	-0.01	0.03		0.8	-0.6	0.72	1.0	-0.39	0.5	0.57	0.45	-0.62	-0.7	-0.73
Net Receivables	0.42	0.03	0.2	-0.31	-0.64	0.57	0.58	0.78	0.39	-0.05	0.37	0.8		-0.33	0.49	0.8	-0.12	0.37	0.39	0.52	-0.24	-0.39	-0.41
Short Term Investments	-0.09	-0.04	-0.47	-0.01	0.52	0.25	-0.09	-0.44	-0.1	0.2	0.2	-0.6	-0.33		-0.52	-0.6	0.56	-0.17	-0.3	-0.26	0.63	0.7	0.77
Capital Surpluse	0.69	0.74	0.89	-0.56	-0.96	-0.13	0.31	0.85	0.64	-0.07	-0.48	0.72	0.49	-0.52		0.72	-0.27	0.9	0.92	0.72	-0.67	-0.77	-0.74
Deferred Long Term Liab	0.45	0.24	0.55	-0.35	-0.81	0.2	0.43	0.8	0.44	-0.01	0.03	1.0	0.8	-0.6	0.72		-0.39	0.5	0.57	0.45	-0.62	-0.7	-0.73
Current Deferred Revenue	0.11	0.02	-0.28	-0.13	0.4	0.41	0.14	-0.19	0.07	0.51	0.07	-0.39	-0.12	0.56	-0.27	-0.39		-0.04	-0.27	0.25	0.49	0.8	0.82
Net Invested Capital	0.86	0.91	0.87	-0.77	-0.85	0.01	0.4	0.76	0.81	0.14	-0.48	0.5	0.37	-0.17	0.9	0.5	-0.04		0.96	0.69	-0.43	-0.53	-0.5
Net Working Capital	0.84	0.86	0.9	-0.76	-0.9	-0.08	0.42	0.77	0.81	0.06	-0.47	0.57	0.39	-0.3	0.92	0.57	-0.27	0.96		0.61	-0.44	-0.71	-0.68
Property Plant Equipment	0.51	0.56	0.56	-0.35	-0.63	0.05	0.22	0.63	0.42	-0.04	-0.38	0.45	0.52	-0.26	0.72	0.45	0.25	0.69	0.61		-0.17	-0.29	-0.28
Capital Stock	-0.14	-0.3	-0.57	0.04	0.66	0.29	0.08	-0.54	-0.11	0.3	0.29	-0.62	-0.24	0.63	-0.67	-0.62	0.49	-0.43	-0.44	-0.17		0.66	0.65
Good Will	-0.34	-0.39	-0.69	0.25	0.83	0.35	-0.14	-0.63	-0.34	0.34	0.34	-0.7	-0.39	0.7	-0.77	-0.7	0.8	-0.53	-0.71	-0.29	0.66		0.97
Intangible Assets	-0.33	-0.37	-0.7	0.24	0.8	0.33	-0.14	-0.61	-0.34	0.32	0.32	-0.73	-0.41	0.77	-0.74	-0.73	0.82	-0.5	-0.68	-0.28	0.65	0.97

Click cells to compare fundamentals

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	7.7 M	9.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC